Clinical Trial Update: A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This report covers the completion of a Phase II clinical trial evaluating lenalidomide for T-cell non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: T-cell Lymphoma | Phase 2 | Status: COMPLETED